To investigate the functional role of DCN in IBC, we first generated stable DCN overexpression in four IBC cell lines [ER−/PR−/HER2+: MDA-IBC339, and SUM190; ER−/PR−/HER2−: SUM149 and BCX01040]. The gene discussed is DCN; the disease is inflammatory breast carcinoma.